Kronik2008 - Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics Lab
About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
This mathematical model describes interactions between glioma tumors and the immune system that may occur following direct intra-tumoral administration of ex-vivo activated alloreactive cytotoxic-T-ly. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_unresolved_tumor_observable_1",
"label": "Initial Unresolved Tumor Observable 1",
"units": "native source value",
"default": 10000000000,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_1",
"description": "Initial Unresolved Tumor Observable 1. Sets the initial value of bundled SBML species `T`."
},
{
"name": "initial_unresolved_tumor_observable_2",
"label": "Initial Unresolved Tumor Observable 2",
"units": "native source value",
"default": 2000000,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_2",
"description": "Initial Unresolved Tumor Observable 2. Sets the initial value of bundled SBML species `C`."
},
{
"name": "initial_unresolved_tumor_observable_3",
"label": "Initial Unresolved Tumor Observable 3",
"units": "native source value",
"default": 0,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_3",
"description": "Initial Unresolved Tumor Observable 3. Sets the initial value of bundled SBML species `F_beta`."
},
{
"name": "initial_unresolved_tumor_observable_4",
"label": "Initial Unresolved Tumor Observable 4",
"units": "native source value",
"default": 0,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_4",
"description": "Initial Unresolved Tumor Observable 4. Sets the initial value of bundled SBML species `F_gamma`."
},
{
"name": "initial_unresolved_tumor_observable_5",
"label": "Initial Unresolved Tumor Observable 5",
"units": "native source value",
"default": 0,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_5",
"description": "Initial Unresolved Tumor Observable 5. Sets the initial value of bundled SBML species `M1`."
},
{
"name": "tumor_growth_rate",
"label": "Tumor Growth Rate",
"units": "native source value",
"default": 0.00035,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.tumor_growth_rate",
"description": "Tumor Growth Rate. Sets bundled SBML parameter `r`."
},
{
"name": "s_dose",
"label": "S Dose",
"units": "native source value",
"default": 300000000,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.s_dose",
"description": "S Dose. Sets bundled SBML parameter `S_dose`."
},
{
"name": "s_dose_initial_parameter",
"label": "S Dose Initial Parameter",
"units": "native source value",
"default": 300000000,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.s_dose_initial_parameter",
"description": "S Dose Initial Parameter. Sets bundled SBML parameter `ModelValue_28`."
}
],
"outputs": [
{
"name": "unresolved_tumor_observable_1",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_1"
},
{
"name": "unresolved_tumor_observable_2",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_2"
},
{
"name": "unresolved_tumor_observable_3",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_3"
},
{
"name": "unresolved_tumor_observable_4",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_4"
},
{
"name": "unresolved_tumor_observable_5",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_5"
},
{
"name": "state",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.state"
},
{
"name": "summary",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.summary"
},
{
"name": "species_labels",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.species_labels"
}
]
},
"title": "Kronik2008 - Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics Lab",
"models": [
{
"path": "models/core",
"alias": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model_state"
],
"from": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.state"
},
{
"to": [
"visualisation.immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model_summary"
],
"from": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.summary"
},
{
"to": [
"visualisation.immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model_species_labels"
],
"from": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.species_labels"
}
],
"package": "kronik2008-improving-alloreactive-ctl-immunotherapy-for-67a4bc59",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "This mathematical model describes interactions between glioma tumors and the immune system that may occur following direct intra-tumoral administration of ex-vivo activated alloreactive cytotoxic-T-ly. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagekronik2008-improving-alloreactive-ctl-immunotherapy-for-67a4bc59
Created2026-05-15
Updated2026-06-13
immunologysbmlbiomodels_ebifaithfulcuratedvisualisationother